Vaccines and Biologicals
Veterinary vaccines and biologicals serve a vital function in the prevention and management of infectious diseases among animals, contributing significantly to the protection of animal health and overall productivity. In India, the manufacture, import, and distribution of these products are subject to a well-defined regulatory framework designed to ensure their safety, efficacy, and consistent quality. This guide offers a thorough understanding of the registration process for manufacturers and importers of veterinary vaccines and biologicals operating within India.
Introduction to the Registration of Veterinary Vaccines and Biologicals
The registration and oversight of veterinary vaccines and biologicals in India fall primarily under the jurisdiction of the Drugs Controller General of India (DCGI), in coordination with the Department of Animal Husbandry and Dairying (DADF) under the Ministry of Fisheries, Animal Husbandry and Dairying. The DCGI is responsible for enforcing the provisions of the Drugs and Cosmetics Act, 1940, along with the Drugs and Cosmetics Rules, 1945. These regulations collectively ensure that all veterinary biological products available in the Indian market meet the highest standards of safety, potency, and effectiveness before they reach end users.
Who Needs to Register?
Registration is mandatory for:
- Domestic manufacturers producing veterinary vaccines and biologicals within India
- Foreign manufacturers seeking to import and market their veterinary biological products in India
- Importers and authorized agents representing overseas manufacturers
- Research institutions and organizations conducting trials involving veterinary biologicals
Licensing Obligations for Manufacturers and Importers
All manufacturers and importers of veterinary vaccines and biologicals in India are required to obtain the appropriate license from the State Drug Control Authority of the state in which their manufacturing facility is situated. This must be preceded by obtaining a No Objection Certificate (NOC) from both CDSCO and DADF. The licensing process encompasses the following categories:
Testing of Vaccines and Drugs
Any new drug or vaccine intended for veterinary use must undergo mandatory testing at a government-approved laboratory before the issuance of Form 45 or Form 46. This testing process ensures that the product meets the required standards of quality, safety, and biological efficacy prior to its commercial release in the market.
Application Categories and Corresponding Permissions
- License to Manufacture → Form 28D (for manufacturers only)
- Import Permission → Form 45 or Form 46
- Test License → Form 11
- Registration Certificate → Form 41
- Import License → Form 10
Step-by-Step Registration Procedure
Step 1: Obtain No Objection Certificate (NOC)
Before applying for any license, the manufacturer or importer must obtain a NOC from:
- CDSCO (Central Drugs Standard Control Organization)
- DADF (Department of Animal Husbandry and Dairying)
The NOC confirms that the product and the applicant meet the preliminary requirements for proceeding with the registration process.
Step 2: Prepare Required Documents
Typical documents required for registration include:
- Completed application form in the prescribed format
- Valid manufacturing license or import license copy
- Product composition and formulation details
- Data on safety, efficacy, and quality testing
- Certificate of Analysis (CoA) from an approved laboratory
- GMP certificate of the manufacturing facility
- Product labels and packaging artwork
- Power of Attorney (for importers or authorized agents)
- Fee payment receipt
Step 3: Submit Application to the Concerned Authority
- Domestic manufacturers submit their application to the respective State Drug Control Authority
- Importers and foreign manufacturers submit through CDSCO via the SUGAM online portal
- All supporting documents must be submitted alongside the application in the prescribed format
Step 4: Laboratory Testing and Evaluation
- The submitted product samples are sent to government-approved laboratories for testing
- The product is evaluated for biological potency, sterility, safety, and compliance with prescribed standards
- Any discrepancies or failures may result in rejection or a request for additional data
Step 5: Regulatory Review and Inspection
- The concerned authority conducts a thorough review of all submitted documents
- A physical inspection of the manufacturing facility may be carried out to verify GMP compliance
- The authority may seek additional clarification or supplementary data from the applicant
Step 6: Issuance of License or Registration Certificate
If all requirements are satisfactorily met:
- The relevant license or registration certificate is issued in the prescribed form
- The certificate includes product details, license number, validity period, and manufacturing site information
- Processing time generally ranges from 30 to 90 working days depending on the product category and authority
Important Points
- All veterinary vaccines and biologicals must be tested at government-approved laboratories before market release
- Licenses are subject to periodic renewal and must be kept valid at all times
- Any change in product composition, labelling, or manufacturing site requires prior approval from the concerned authority
- Non-compliance with regulatory requirements may result in suspension or cancellation of the license
- Imported veterinary biologicals must comply with both central and state-level regulations before they can be marketed in India
- Manufacturers must maintain detailed batch records and make them available for inspection upon request
The registration of veterinary vaccines and biologicals in India is a structured and mandatory process governed by the Drugs and Cosmetics Act, 1940. All manufacturers and importers must secure the appropriate licenses, comply with testing requirements, and maintain ongoing regulatory compliance to legally manufacture or market these products in India. Ensuring timely registration and renewal is essential to avoid disruptions in production, import, or sale of veterinary biological products.